Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a digital tool help smokers decide on lung cancer screening?

NCT ID NCT07716527

ENROLLING_BY_INVITATION Knowledge-focused Sponsor: Rutgers, The State University of New Jersey Source: ClinicalTrials.gov ↗

First seen Jul 21, 2026 · Last updated Jul 22, 2026 · Updated 1 time

Summary

This study tests a web-based digital tool designed to help people aged 50–80 who smoke or recently quit make informed decisions about lung cancer screening. The tool includes a personalized risk calculator, patient stories, and smoking cessation resources. Researchers compare its usability and effectiveness against standard educational materials from the American Cancer Society.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
a web-based digital health tool prototype containing lung cancer screening information, a personalized risk calculator, patient stories, and smoking cessation resources
What this could lead to
If successful, this tool could help more people make informed decisions about lung cancer screening, potentially catching cancers earlier.
What could go wrong
This is a small pilot study testing a prototype, so the tool may not be effective or widely adopted. Results may not apply to all populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUNG CANCER SCREENING are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LUNG CANCER SCREENING

Contacts and locations

Locations

  • Rutgers Cancer Institute of New Jersey

    New Brunswick, New Jersey, 08901, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.